We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+10.52%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$287B
AUM Growth
+$18.5B
Cap. Flow
-$5.09B
Cap. Flow %
-1.77%
Top 10 Hldgs %
26.06%
Holding
3,383
New
280
Increased
1,384
Reduced
1,249
Closed
179

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$672M
2
AMAT icon
Applied Materials
AMAT
+$241M
3
KVUE icon
Kenvue
KVUE
+$220M
4
CRM icon
Salesforce
CRM
+$210M
5
PYPL icon
PayPal
PYPL
+$195M

Sector Composition

Rank Sector Weight
1 Technology 27.89%
2 Healthcare 12.64%
3 Financials 11.26%
4 Consumer Discretionary 11%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
3101
DELISTED
OptiNose
OPTN
$126K ﹤0.01%
+6,813
New +$161K
GRSD
3102
Grandstand Ltd
GRSD
$55.9M
$125K ﹤0.01%
12,214
– –
PEPG icon
3103
PepGen
PEPG
$179M
$124K ﹤0.01%
13,848
-18,578
-57% -$243K
DSP icon
3104
Viant Technology
DSP
$258M
$123K ﹤0.01%
26,666
+758
+3% +$3.36K
SNFCA icon
3105
Security National Financial
SNFCA
$228M
$121K ﹤0.01%
+17,406
New +$111K
IVAC
3106
DELISTED
Intevac Inc
IVAC
$118K ﹤0.01%
+31,595
New +$169K
LPTV
3107
DELISTED
Loop Media, Inc.
LPTV
$118K ﹤0.01%
+49,397
New +$193K
LRMR icon
3108
Larimar Therapeutics
LRMR
$320M
$112K ﹤0.01%
+35,655
New +$145K
CURV icon
3109
Torrid Holdings
CURV
$234M
$111K ﹤0.01%
39,543
– –
SCOR icon
3110
Comscore
SCOR
$74.6M
$111K ﹤0.01%
6,846
– –
OKUR
3111
OnKure Therapeutics
OKUR
$117M
$111K ﹤0.01%
+1,686
New +$136K
PAYS icon
3112
Paysign
PAYS
$715M
$110K ﹤0.01%
+45,010
New +$138K
DAO
3113
Youdao
DAO
$1.77B
$109K ﹤0.01%
22,600
– –
METCB icon
3114
Ramaco Resources Class B
METCB
$287M
$108K ﹤0.01%
+11,251
New +$106K
TDCX
3115
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$108K ﹤0.01%
13,600
– –
HRTX icon
3116
Heron Therapeutics
HRTX
$55.9M
$106K ﹤0.01%
91,752
-629,279
-87% -$1.12M
VATE icon
3117
INNOVATE Corp
VATE
$106M
$105K ﹤0.01%
+6,027
New +$129K
DOYU
3118
DouYu International Holdings
DOYU
$139M
$104K ﹤0.01%
9,922
– –
LENZ
3119
LENZ Therapeutics
LENZ
$123M
$103K ﹤0.01%
+5,677
New +$113K
TGAN
3120
DELISTED
Transphorm, Inc. Common Stock
TGAN
$103K ﹤0.01%
30,360
– –
ATRA icon
3121
Atara Biotherapeutics
ATRA
$88.4M
$103K ﹤0.01%
2,549
-63,935
-96% -$3.62M
KWY
3122
Kingsway Corp
KWY
$261M
$101K ﹤0.01%
+12,374
New +$106K
NBP
3123
NovaBridge Biosciences American Depositary Shares
NBP
$160M
$100K ﹤0.01%
33,500
– –
RMTI icon
3124
Rockwell Medical
RMTI
$33.7M
$99.3K ﹤0.01%
1,819
– –
NL icon
3125
NLI Holdings
NL
$343M
$99.1K ﹤0.01%
17,922
– –

Similar funds

Nuveen's Q2 2023 Portfolio in Review

As of Q2 2023, Nuveen held 3,383 positions worth $287B, up 6.9% from $269B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Nuveen's Q2 2023 filing shows 280 new, 1,384 increased, 1,249 reduced and 179 closed positions. Its largest new stake was Kenvue: 8,445,273 shares worth $223M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $1.25B.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2023 buy was Kenvue: 8,445,273 shares worth $223M.
  • Nuveen added most to Amazon in Q2 2023, an estimated $672M increase.
  • Nuveen's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.25B.
  • Nuveen fully exited Qualtrics International Inc. Class A Common Stock in Q2 2023, selling an estimated $130M.
  • Nuveen's ten largest holdings make up 26% of its $287B portfolio in Q2 2023.
  • Nuveen opened 280 new positions and closed 179 in Q2 2023.
  • Nuveen's portfolio value rose 6.9% quarter-over-quarter to $287B.

Based on Nuveen's 13F filing for Q2 2023, filed 14 Aug 2023.